Bejelentkezés Regisztrálj ingyen

Alimera Sciences Jövedelem

Mi az Alimera Sciences Jövedelem?

A Jövedelem az Alimera Sciences Inc. - -$15.27

Mi a Jövedelem meghatározása?

A közös részvényesek számára rendelkezésre álló nettó jövedelem egyenlő a nettó jövedelemmel mínusz a kifizetett előnyben részesített osztalékokkal.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Jövedelem a Health Care szektor a NASDAQ-on cégekben a Alimera Sciences -hoz képest

Mit csinál Alimera Sciences?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

jövedelem -hoz hasonló cégek Alimera Sciences